Any potential US tariffs on Indian pharmaceutical exports could primarily affect American consumers, as stated by Pharmexcil.
US companies eagerly offshored their supply chains to drive down costs and boost profits. But today, the world economy is a ...
Donald Trump's proposal to impose a 25% or more tariff on pharmaceutical imports into the United States holds significant ...
US President Donald Trump’s threat to slap a 25 per cent tariff on foreign car imports and pharmaceuticals could spark a new ...
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand ...